Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Account Payables (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Change in Account Payables for 17 consecutive years, with -$90.0 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 117.41% to -$90.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.0 million through Dec 2025, down 101.09% year-over-year, with the annual reading at -$2.0 million for FY2025, 101.09% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$90.0 million at Bristol Myers Squibb, down from $160.0 million in the prior quarter.
  • The five-year high for Change in Account Payables was $517.0 million in Q4 2024, with the low at -$374.0 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $36.7 million, with a median of -$3.0 million recorded in 2022.
  • Peak annual rise in Change in Account Payables hit 713.04% in 2023, while the deepest fall reached 768.42% in 2023.
  • Over 5 years, Change in Account Payables stood at $226.0 million in 2021, then surged by 79.2% to $405.0 million in 2022, then grew by 9.63% to $444.0 million in 2023, then increased by 16.44% to $517.0 million in 2024, then tumbled by 117.41% to -$90.0 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$90.0 million, $160.0 million, and $13.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.